Cargando…
Biomarkers for predicting response to long‐term high dose aspirin therapy in aspirin‐exacerbated respiratory disease
INTRODUCTION: Aspirin‐exacerbated respiratory disease (AERD) is a phenotype of asthma characterized by eosinophilic inflammation in the airways, mast cell activation, cysteinyl leukotriene overproduction, and acute respiratory reactions on exposure to cyclooxygenase‐1 inhibitors. Aspirin desensitiza...
Autores principales: | Mastalerz, Lucyna, Tyrak, Katarzyna E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8361815/ https://www.ncbi.nlm.nih.gov/pubmed/34429873 http://dx.doi.org/10.1002/clt2.12048 |
Ejemplares similares
-
Biomarkers for predicting response to aspirin therapy in aspirin‐exacerbated respiratory disease
por: Tyrak, Katarzyna E., et al.
Publicado: (2021) -
Local and Systemic Production of Pro-Inflammatory Eicosanoids Is Inversely Related to Sensitization to Aeroallergens in Patients with Aspirin-Exacerbated Respiratory Disease
por: Potaczek, Daniel P., et al.
Publicado: (2022) -
Audit of nasal lysine aspirin therapy in recalcitrant aspirin exacerbated respiratory disease
por: Howe, Rachel, et al.
Publicado: (2014) -
Aspirin Exacerbated Respiratory Disease
por: Teran, Luis M., et al.
Publicado: (2012) -
The utility of biomarkers in diagnosis of aspirin exacerbated respiratory disease
por: Comhair, Suzy A. A., et al.
Publicado: (2018)